0001209191-11-052181.txt : 20111019
0001209191-11-052181.hdr.sgml : 20111019
20111019160827
ACCESSION NUMBER: 0001209191-11-052181
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111017
FILED AS OF DATE: 20111019
DATE AS OF CHANGE: 20111019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANADYS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001128495
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223193172
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5871 OBERLIN DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585303600
MAIL ADDRESS:
STREET 1: 5871 OBERLIN DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: QVT Fund LP
CENTRAL INDEX KEY: 0001290165
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50632
FILM NUMBER: 111148221
BUSINESS ADDRESS:
STREET 1: WALKERS SPV, WALKERS HOUSE
STREET 2: P.O. BOX 908GT, MARY STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: 00000
BUSINESS PHONE: 212-705-8800
MAIL ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: QVT Associates GP LLC
CENTRAL INDEX KEY: 0001290166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50632
FILM NUMBER: 111148222
BUSINESS ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-705-8800
MAIL ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
c23468_4x0.xml
MAIN DOCUMENT DESCRIPTION
X0304
4
2011-10-17
0001128495
ANADYS PHARMACEUTICALS INC
ANDS
0001290166
QVT Associates GP LLC
1177 AVENUE OF THE AMERICAS
9TH FLOOR
NEW YORK
NY
10036
0
0
1
0
0001290165
QVT Fund LP
WALKER HOUSE 87 MARY STREET
GEORGE TOWN
E9
Ky1-9005
CAYMAN ISLANDS
0
0
1
0
Common Stock, $0.001 par value
2011-10-17
4
S
0
650100
3.68
D
10770554
I
Through QVT Fund LP and Quintessence Fund L.P.
On October 17, 2011, QVT Fund LP sold 586,287 shares of Common Stock and Quintessence Fund L.P. sold 63,813 shares of Common Stock.
As a result, QVT Fund LP directly beneficially owns 9,713,359 shares of Common Stock and Quintessence Fund L.P. directly beneficially
owns 1,057,195 shares of Common Stock. QVT Associates GP LLC, as General Partner of QVT Fund LP and Quintessence Fund L.P., may
be deemed to beneficially own the aggregate number of shares of Common Stock owned by QVT Fund LP and Quintessence Fund L.P. and accordingly,
QVT Associates GP LLC may be deemed to be the indirect beneficial owner of an aggregate amount of 10,770,554 shares of Common
Stock.
/s/ Tracy Fu, Managing Member
2011-10-19